NYSE:IVC - Invacare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $6.69 -0.36 (-5.11 %) (As of 05/19/2019 12:43 PM ET)Previous Close$6.69Today's Range$6.5685 - $7.0052-Week Range$3.05 - $20.00Volume334,521 shsAverage Volume419,403 shsMarket Capitalization$225.85 millionP/E RatioN/ADividend Yield0.75%Beta2.25 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio. Receive IVC News and Ratings via Email Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:IVC Previous Symbol CUSIP46120310 CIK742112 Webwww.invacare.com Phone440-329-6000Debt Debt-to-Equity Ratio0.78 Current Ratio1.97 Quick Ratio1.29Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$972.35 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$10.38 per share Price / Book0.64Profitability EPS (Most Recent Fiscal Year)($1.32) Net Income$-43,920,000.00 Net Margins-4.56% Return on Equity-11.69% Return on Assets-4.53%Miscellaneous Employees4,200 Outstanding Shares33,760,000Market Cap$225.85 million Next Earnings Date8/6/2019 (Estimated) OptionableOptionable Invacare (NYSE:IVC) Frequently Asked Questions What is Invacare's stock symbol? Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC." How often does Invacare pay dividends? What is the dividend yield for Invacare? Invacare declared a quarterly dividend on Friday, May 17th. Stockholders of record on Friday, July 5th will be given a dividend of $0.0125 per share on Monday, July 22nd. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date is Wednesday, July 3rd. View Invacare's Dividend History. How were Invacare's earnings last quarter? Invacare Co. (NYSE:IVC) released its earnings results on Monday, May, 6th. The health services provider reported ($0.32) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.01. The health services provider had revenue of $223.40 million for the quarter, compared to analysts' expectations of $229.93 million. Invacare had a negative net margin of 4.56% and a negative return on equity of 11.69%. The company's revenue for the quarter was down 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.35) earnings per share. View Invacare's Earnings History. When is Invacare's next earnings date? Invacare is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Invacare. What price target have analysts set for IVC? 1 equities research analysts have issued 12-month price objectives for Invacare's shares. Their predictions range from $15.00 to $15.00. On average, they expect Invacare's share price to reach $15.00 in the next twelve months. This suggests a possible upside of 124.2% from the stock's current price. View Analyst Price Targets for Invacare. What is the consensus analysts' recommendation for Invacare? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare. What are Wall Street analysts saying about Invacare stock? Here are some recent quotes from research analysts about Invacare stock: 1. According to Zacks Investment Research, "Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. " (4/17/2019) 2. Needham & Company LLC analysts commented, "IVC’s 4Q18 revenue and EPS beat consensus. In 4Q18, IVC’s segment growth improved except for NA/HME, which slowed. Free cash flow also improved in 4Q18 and IVC achieved positive EBITDA. IVC updated its longer-term EBITDA guidance and now expects to reach a run rate of $85-105M by the end of 2020 (vs. prior guidance of $100M by 3Q20). And while the 4Q18 results were encouraging, we believe more details on IVC’s updated Transformation Plan will be just as important. Given the improvements in 4Q18 and potential for more aggressive restructuring, we reiterate our Buy rating." (2/14/2019) Has Invacare been receiving favorable news coverage? News articles about IVC stock have been trending positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Invacare earned a daily sentiment score of 2.2 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of Invacare's key competitors? Some companies that are related to Invacare include Establishment Labs (ESTA), RTI Surgical (RTIX), ConforMIS (CFMS), Sientra (SIEN), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Precision Therapeutics (AIPT), Allied Healthcare Products (AHPI), Avitar (AVTI), COLOPLAST A/S/ADR (CLPBY) and Halyard Health (HYH). What other stocks do shareholders of Invacare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include ImmunoGen (IMGN), Immunomedics (IMMU), Lexicon Pharmaceuticals (LXRX), TherapeuticsMD (TXMD), ResMed (RMD), Abeona Therapeutics (ABEO), Array Biopharma (ARRY), Amicus Therapeutics (FOLD), Horizon Therapeutics (HZNP) and Jazz Pharmaceuticals (JAZZ). Who are Invacare's key executives? Invacare's management team includes the folowing people: Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 51)Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 56)Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 61)Ms. Darcie L. Karol, Sr. VP of HR (Age 52)Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 51) Who are Invacare's major shareholders? Invacare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.80%), Elk Creek Partners LLC (9.56%), Dimensional Fund Advisors LP (8.20%), Royce & Associates LP (6.39%), Goldman Sachs Group Inc. (3.83%) and Keeley Teton Advisors LLC (3.41%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare. Which institutional investors are selling Invacare stock? IVC stock was sold by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Goldman Sachs Group Inc., Kennedy Capital Management Inc., Marshall Wace North America L.P., Alambic Investment Management L.P., Spark Investment Management LLC, Royce & Associates LP and OppenheimerFunds Inc.. Company insiders that have sold Invacare company stock in the last year include Anthony Laplaca, Baiju R Shah, C Martin Harris and Dean J Childers. View Insider Buying and Selling for Invacare. Which institutional investors are buying Invacare stock? IVC stock was purchased by a variety of institutional investors in the last quarter, including Keeley Teton Advisors LLC, Marshall Wace LLP, Renaissance Technologies LLC, Wells Fargo & Company MN, Essex Investment Management Co. LLC, North Run Capital LP, BlackRock Inc. and Acadian Asset Management LLC. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare. How do I buy shares of Invacare? Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Invacare's stock price today? One share of IVC stock can currently be purchased for approximately $6.69. How big of a company is Invacare? Invacare has a market capitalization of $225.85 million and generates $972.35 million in revenue each year. The health services provider earns $-43,920,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. Invacare employs 4,200 workers across the globe. What is Invacare's official website? The official website for Invacare is http://www.invacare.com. How can I contact Invacare? Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected] MarketBeat Community Rating for Invacare (NYSE IVC)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 192 (Thanks for Voting!)Underperform Votes: 229 (Thanks for Voting!)Total Votes: 421MarketBeat's community ratings are surveys of what our community members think about Invacare and other stocks. Vote "Outperform" if you believe IVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: What is the formula for calculating total return? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.